Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

NCT00896493 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Mycoses
Sezary Syndrome
Lymphoma, T-Cell, Cutaneous
Bone Marrow Transplant Failure
Lymphoma, Non-Hodgkin
Cutaneous T-cell Lymphoma

Interventions

DRUG: anti-thymocyte globulin
DRUG: cyclosporine
RADIATION: Lymphoid radiation

Sponsor

Stanford University